UAE Maintains Pole Position In The MEA Q410 Business Environment Ratings

In BMI's Q410 Pharmaceuticals & Healthcare Business Environment Ratings (BERs), the Middle East & Africa region scored a total of 45.40 out of a possible 100. Despite scoring the lowest of all regions for the quarter, BMI notes that the attractiveness of the region to pharmaceutical firms stems from the fact that its countries fall within the emerging market category - which we believe will drive growth in the pharmaceuticals & healthcare industry - boosting the risk and reward scores assigned to markets in the region in the long term. The importance of emerging markets to large multinational drugmakers cannot

To read the full article, please choose one of the following options: